HTA43 The Practice of Drug Clinical Comprehensive Evaluation in China and the Implications in Patient Access to Innovative Drugs
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1175
https://www.valueinhealthjournal.com/article/S1098-3015(22)01376-6/fulltext
Title :
HTA43 The Practice of Drug Clinical Comprehensive Evaluation in China and the Implications in Patient Access to Innovative Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01376-6&doi=10.1016/j.jval.2022.04.1175
First page :
Section Title :
Open access? :
No
Section Order :
11051